Sacha Pfeiffer
Sacha Pfeiffer
CRITIC
img-contested
N/A
0 reviews
PUBLIC
img-contested
N/A
0 reviews

RECENT ARTICLES

Sort by:
No Rating
Business As Usual During The Pandemic, This Time Through Plexiglass

Business As Usual During The Pandemic, This Time Through Plexiglass

Does Plexiglass Keep You Safe From Coronavirus? Sales Rise As Businesses Reopen Demand for plexiglass has skyrocketed due to the coronavirus as businesses worldwide install protective barriers.Heard onToggle more optionsWith coronavirus cases surging in the U.S., many people are concluding they'll have to learn to live with the virus until a COVID-19 vaccine is widely available — and that's led to a huge increase in orders for plexiglass and other types of clear plastic barriers meant to keep us safe. "Demand is ridiculously high," said Jackie Yong, a 17-year employee of J. Freeman, Inc., a...

July 3, 2020
Share
Save
Review
No Rating
Trump's Plan For Drive-Up COVID-19 Tests At Stores Yields Few Results

Trump's Plan For Drive-Up COVID-19 Tests At Stores Yields Few Results

Trump Plan For Drive-Up COVID-19 Tests At Stores Yields Few Results The White House promised widespread COVID-19 testing at CVS, Target, Walgreens and Walmart locations nationwide. But months later, testing is being offered at only a tiny fraction of their stores.Heard onToggle more optionsTwice now, on and again on April 27, President Trump gathered some of the country's top corporate executives — from test producers to lab processors to major retailers — to tout his plan to make COVID-19 testing widely available. His vision: Blanket the country in drive-through testing sites. The...

June 1, 2020
Share
Save
Review
No Rating
VIDEO: What The U.S. Is Doing About Its Testing Swab Shortage

VIDEO: What The U.S. Is Doing About Its Testing Swab Shortage

Video: Why There's Still A Coronavirus Testing Swab Shortage : Shots - Health News To contain the coronavirus, the U.S. needs to be able to test a lot of people. But we're facing a shortage of a key ingredient: the swab. Here's why these swabs are so hard to source.NPRWidespread testing for the coronavirus is key to safely reopening the country, but the U.S. has struggled for months to get to the level of testing many experts say we need — even as states and cities begin to loosen restrictions. Part of the problem is that a test for the coronavirus is not a single device. Testing entails...

May 25, 2020
Share
Save
Review
No Rating
Business As Usual During The Pandemic, This Time Through Plexiglass

Business As Usual During The Pandemic, This Time Through Plexiglass

Does Plexiglass Keep You Safe From Coronavirus? Sales Rise As Businesses Reopen Demand for plexiglass has skyrocketed due to the coronavirus as businesses worldwide install protective barriers.Heard onToggle more optionsWith coronavirus cases surging in the U.S., many people are concluding they'll have to learn to live with the virus until a COVID-19 vaccine is widely available — and that's led to a huge increase in orders for plexiglass and other types of clear plastic barriers meant to keep us safe. "Demand is ridiculously high," said Jackie Yong, a 17-year employee of J. Freeman, Inc., a...

July 3, 2020
Share
Save
Review
No Rating
U.S. Races To Increase Domestic Production Of Swabs For Coronavirus Testing

U.S. Races To Increase Domestic Production Of Swabs For Coronavirus Testing

U.S. Races To Increase Domestic Production Of Swabs For Coronavirus Testing There were early warnings of COVID-19 testing supply shortages, such as swabs. The federal government took until late April to ramp up domestic production. Will the U.S. be able to catch up to demand?Heard onToggle more optionsThere were early warnings of COVID-19 testing supply shortages, such as swabs. The federal government took until late April to ramp up domestic production. Will the U.S. be able to catch up to demand?RACHEL MARTIN, HOST:We've been hearing that a shortage of supplies has limited our coronavirus...

May 13, 2020
Share
Save
Review
No Rating
A Month After Emergency Declaration, Trump's Promises Largely Unfulfilled

A Month After Emergency Declaration, Trump's Promises Largely Unfulfilled

In March, Trump Promised Resources To Fight The Pandemic. Few Happened On March 13, President Trump promised to mobilize private and public resources to respond to the coronavirus. NPR followed up on each promise and found little action had been taken.Heard onToggle more optionsUpdated at 10:10 p.m. ET One month ago today, President Trump declared a national emergency. In a Rose Garden address, flanked by leaders from giant retailers and medical testing companies, he promised a mobilization of public and private resources to attack the coronavirus. "We've been working very hard on this....

April 13, 2020
Share
Save
Review
No Rating
U.S. Hospitals Prepare Guidelines For Who Gets Care Amid Coronavirus Surge

U.S. Hospitals Prepare Guidelines For Who Gets Care Amid Coronavirus Surge

U.S. Hospitals Prepare Guidelines For Who Gets Care Amid Coronavirus Surge Doctors in Italy are overwhelmed by coronavirus cases and prioritizing which patients get care. Many U.S. doctors could soon be making the same life-or-death decisions.Heard onToggle more optionsAs COVID-19 spreads rapidly through the United States, many American doctors could soon be making the decisions that overwhelmed health care workers in Italy are already facing: Which patients get lifesaving treatment, and which ones do not? Every accredited hospital in the U.S. is required to have some mechanism for...

March 21, 2020
Share
Save
Review
No Rating
News Brief: Impeachment Case, AstraZeneca Vaccine, U.S. COVID-19 Cases

News Brief: Impeachment Case, AstraZeneca Vaccine, U.S. COVID-19 Cases

News Brief: Impeachment Case, AstraZeneca Vaccine, U.S. COVID-19 Cases Trump's impeachment trial begins Tuesday. South Africa stops using AstraZeneca's COVID-19 vaccine — it may not be as effective against a variant. U.S vaccinations accelerate, new infections decline.Heard onToggle more optionsTrump's impeachment trial begins Tuesday. South Africa stops using AstraZeneca's COVID-19 vaccine — it may not be as effective against a variant. U.S vaccinations accelerate, new infections decline.RACHEL MARTIN, HOST:It's happening again - another Senate trial to impeach Donald Trump, but this time,...

February 8, 2021
Share
Save
Review
No Rating
Novavax Researcher Says No Chance Of A 'Shortcut' In Vaccine Safety

Novavax Researcher Says No Chance Of A 'Shortcut' In Vaccine Safety

Novavax Researcher Says No Chance Of A 'Shortcut' In Vaccine Safety : Coronavirus Updates Vaccine maker Novavax is starting a large coronavirus vaccine trial in the U.K. Gregory Glenn, the company's president of research and development, talks with NPR about how vaccines are tested.Heard onToggle more optionsNovavax, a vaccine maker in Maryland, is becoming the 10th coronavirus vaccine candidate to enter the final phase of testing, called phase 3. The trial is taking place in the U.K., where researchers plan to enroll up to 10,000 adults of various ages in the next four to six weeks. Half...

September 25, 2020
Share
Save
Review
  • Total 9 items
  • 1
OUTLETS
npr.org

npr.org

CRITIC
img-trusted
94%
PUBLIC
img-trusted
86%